MLchartDataset catalogue

Amplimexon

Term · Oncology and biomedicine · MLC-T-ONC-000470

A substance that is being studied in the treatment of some types of cancer, including pancreatic, lung, breast, prostate, melanoma, and multiple myeloma. It belongs to the family of drugs called cyanoaziridine derivatives. Also called imexon.

Table 1. Record
IdentifierMLC-T-ONC-000470
FieldOncology and biomedicine
Synonymsimexon
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-000470",
  "term": "Amplimexon",
  "field": "Oncology and biomedicine",
  "definition": "A substance that is being studied in the treatment of some types of cancer, including pancreatic, lung, breast, prostate, melanoma, and multiple myeloma. It belongs to the family of drugs called cyanoaziridine derivatives. Also called imexon.",
  "synonyms": [
    "imexon"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/amplimexon/"
}

Record 1,008 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.